Ambrx Biopharma appoints Stephen Glover as board chairman
- Ambrx Biopharma (NASDAQ:AMAM) on Thursday said it had appointed Stephen Glover as chairman of its board of directors.
- The company's former chair, Katrin Rupalla, has resigned from the board to pursue another opportunity, AMAM said in a statement.
- According to AMAM, Glover has over 30 years of experience in the biopharmaceutical and life sciences industries.
- Glover is currently the co-founder, chairman and CEO of ZyVersa Therapeutics (ZVSA).